ISRCTN11735271已完成不适用
Phase IIa clinical study of 64CuCl2: efficacy and safety of a new tracer for urologic tumors
Ospedale Civile Spirito Santo0 个研究点目标入组 25 人开始时间: 2017年11月21日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 25
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Subject aged over 18 at diagnosis
- •2. Subject with renal or bladder or prostate or penile cancer waiting for surgical excision or imaging restaging due to progressive disease
- •3. Availability of already done cross-sectional imaging in the last month
- •4. Karnofsky index >80%
- •5. Absence of relevant comorbidities (see exclusion criteria)
- •6. Full mental ability to understand the value and the relevance of the protocol and the related procedures showed in the Informativa per il soggetto”
- •7. Full mental ability in order to give informed consent
- •8. Negative pregnancy test for women potentially at risk for pregnancies
排除标准
- •1. Hb levels < 10 gr/dL
- •2. Presence of copper metabolism diseases (Menkes or Wilson diseases)
- •3. Previous participation in clinical trial involving ionizing radiation for diagnostic or therapeutic finality in the last year
- •4. Working exposition to ionizing radiation
- •5. Each condition that could alter and reduce the compliance of the subject to the participation to the study protocol
- •6. Mental inability to fully understand the Informativa per il soggetto”
研究者
相似试验
进行中（未招募）
1 期
Efficacy and safety of a new tracer for urologic tumorsGenitourinary tract tumors in male patientsEUCTR2017-000940-17-IT20
进行中（未招募）
1 期
Diagnostic value of 64CuCl2 in high grade gliomapediatric patients with HGG/DIPGMedDRA version: 20.0Level: SOCClassification code 10029104Term: Neoplasms benign, malignant and unspecified (incl cysts and polyps)System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2018-004667-30-ITENTE OSPEDALIERO OSPEDALI GALLIERA10
进行中（未招募）
1 期
Diagnostic value of 64CuCl2-PET/MRI in prostate cancer relapse.Prostate cancer patients who showed biochemical relapse after surgery or first-line treatment with radiotherapyMedDRA version: 20.0Level: SOCClassification code 10038604Term: Reproductive system and breast disordersSystem Organ Class: 10038604 - Reproductive system and breast disordersEUCTR2014-005140-18-ITENTE OSPEDALIERO OSPEDALI GALLIERA50
已完成
不适用
The mid-term clinical study about the effect of curcumin for knee osteoarthritisKnee osteoarthritisJPRN-UMIN000011074ational Hospital Organization Kyoto Medical Center50
招募中
2 期
Phase II clinical trial on clinical efficacy and safety of combination therapy of boron neutron capture therapy and bevacizumab for recurrent glioma with poor prognosisRecurrent malignant gliomaJPRN-UMIN000029144Osaka Medical College20